Features and properties of revefenacin

Alternative names	1160724; GSK 1160724; TD-4028; YUPELRI™
Class	Antiasthmatics; biphenyl compounds; bronchodilators; carbamates; piperidines
Mechanism of action	Muscarinic receptor antagonist
Route of administration	Inhalation
Pharmacodynamics	Inhibits muscarinic receptor M3 in the airway smooth muscle, leading to bronchodilation
Pharmacokinetics (after inhaled administration)	Time to Cmax 14–41 min; elimination half-life 22–70 h
Most frequent adverse events	Cough, headache, upper respiratory tract infection, nasopharyngitis and back pain
ATC codes
WHO ATC code	R03B-B (Anticholinergics)
EphMRA ATC code	R3G3 (Anticholinergics-plain, inhalant)
Chemical name	[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate